Myeloma Flashcards

1
Q

What is multiple myeloma (MM)?

A

Multiple myeloma (MM) is a haematological malignancy characterised by plasma cell proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the median age at presentation for multiple myeloma?

A

The median age at presentation is 70 years old.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the mnemonic CRABBI stand for in multiple myeloma?

A

CRABBI stands for Calcium, Renal, Anaemia, Bleeding, Bones, and Infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the primary cause of hypercalcaemia in multiple myeloma?

A

Hypercalcaemia is primarily due to increased osteoclastic bone resorption caused by local cytokines released by the myeloma cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the symptoms associated with hypercalcaemia?

A

Symptoms include constipation, nausea, anorexia, and confusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does multiple myeloma affect renal function?

A

Monoclonal production of immunoglobulins results in light chain deposition within the renal tubules, causing renal damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are common presentations of renal impairment in myeloma?

A

Common presentations include dehydration and increasing thirst.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What causes anaemia in multiple myeloma?

A

Bone marrow crowding suppresses erythropoiesis, leading to anaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the symptoms of anaemia in multiple myeloma?

A

Symptoms include fatigue and pallor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the effect of bone marrow crowding on bleeding risk?

A

Bone marrow crowding results in thrombocytopenia, increasing the risk of bleeding and bruising.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What causes lytic bone lesions in multiple myeloma?

A

Bone marrow infiltration by plasma cells and cytokine-mediated osteoclast overactivity creates lytic bone lesions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the symptoms associated with lytic bone lesions?

A

Symptoms may include pain (especially in the back) and an increased risk of pathological fractures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does multiple myeloma affect infection risk?

A

A reduction in the production of normal immunoglobulins results in increased susceptibility to infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some other features of multiple myeloma?

A

Other features include amyloidosis (e.g., macroglossia), carpal tunnel syndrome, neuropathy, and hyperviscosity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What blood tests are used in the investigation of multiple myeloma?

A

Blood tests include full blood count (anaemia), peripheral blood film (rouleaux formation), urea and electrolytes (renal failure), and bone profile (hypercalcaemia).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does protein electrophoresis reveal in multiple myeloma?

A

It shows raised concentrations of monoclonal IgA/IgG proteins in the serum and Bence Jones proteins in the urine.

17
Q

What is the significance of bone marrow aspiration in multiple myeloma?

A

Bone marrow aspiration confirms the diagnosis if the number of plasma cells is significantly raised.

18
Q

What imaging techniques are used in the investigation of multiple myeloma?

A

Imaging techniques include skeletal surveys, whole-body MRI, and X-rays (notably ‘rain-drop skull’).

19
Q

What are the major diagnostic criteria for multiple myeloma?

A

Major criteria include plasmacytoma, 30% plasma cells in a bone marrow sample, and elevated levels of M protein in blood or urine.

20
Q

What are the minor diagnostic criteria for multiple myeloma?

A

Minor criteria include 10% to 30% plasma cells in a bone marrow sample, minor elevations in M protein, osteolytic lesions, and low levels of antibodies in the blood.

21
Q

What is multiple myeloma (MM)?

A

Multiple myeloma (MM) is a haematological malignancy characterised by plasma cell proliferation.

22
Q

How does multiple myeloma arise?

A

It arises due to genetic mutations which occur as B-lymphocytes differentiate into mature plasma cells.

23
Q

What is the management goal for myeloma?

A

Management aims to control symptoms, reduce complications and prolong survival.

24
Q

What types of drugs are used in the treatment of myeloma?

A

A combination of drugs is used including induction therapy, targeted drugs, chemotherapy, and steroids.

25
Q

What are examples of targeted drugs for myeloma?

A

Examples include thalidomide, lenalidomide, bortezomib, and daratumumab.

26
Q

What are examples of chemotherapy drugs for myeloma?

A

Examples include cyclophosphamide and melphalan.

27
Q

What is autologous hematopoietic cell transplantation?

A

It involves the removal of a patient’s own stem cells prior to chemotherapy, which are then replaced after chemotherapy.

28
Q

What are the benefits of autologous hematopoietic cell transplantation?

A

It prolongs both event-free and overall survival when compared with non-transplant strategies.

29
Q

Who is typically suitable for stem cell transplantation?

A

Typically, it is younger, healthier patients who are suitable for stem cell transplantation and rigorous chemotherapy regimes.

30
Q

Why is allogenic hematopoietic cell transplantation not commonly used in myeloma?

A

Due to high rates of overall mortality and symptoms of graft-versus-host disease.

31
Q

What complications are managed in multiple myeloma treatment?

A

Complications include pain, pathological fractures, infection, venous thromboembolism, and fatigue.

32
Q

How is pain managed in multiple myeloma?

A

Pain is treated with analgesia using the WHO analgesic ladder.

33
Q

What is given to prevent and manage osteoporosis in myeloma patients?

A

Zoledronic acid is given to prevent and manage osteoporosis and fragility fractures.

34
Q

What vaccinations do myeloma patients receive?

A

Patients receive annual influenza vaccinations.

35
Q

What therapy may myeloma patients receive for infection management?

A

They may receive Immunoglobulin replacement therapy.

36
Q

What is done for venous thromboembolism prophylaxis in myeloma patients?

A

Venous thromboembolism prophylaxis is provided.

37
Q

How is fatigue managed in myeloma patients?

A

All possible underlying causes are treated, and if symptoms persist, consider an erythropoietin analogue.